Horizon Therapeutics PLC (HZNP)

88.65 +2.46  +2.85% NASDAQ Mar 5, 20:00 USD
View Full Chart
Price Chart
View All HZNP News

News

View All Events

Events

Date Type Description
05/06/2021 Earnings Horizon Therapeutics PLC First Quarter Earnings Results for 2021
05/06/2021 Misc Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2021
02/24/2021 Earnings Horizon Therapeutics PLC Fourth Quarter Earnings Result for 2020
02/24/2021 08:00 EST Misc Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2020
11/02/2020 Earnings Horizon Therapeutics PLC Third Quarter Earnings Result for 2020
11/02/2020 08:00 EST Misc Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2020
08/05/2020 08:00 EDT Misc Horizon Therapeutics PLC Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Horizon Therapeutics PLC Second Quarter Earnings Result for 2020
05/06/2020 08:00 EDT Misc Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Horizon Therapeutics PLC First Quarter Earnings Result for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.horizontherapeutics.com
  • Investor Relations URL: http://ir.horizon-pharma.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 06, 2021
  • Last Earnings Release: Feb. 24, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.88%
JCNIX Janus Henderson Contrarian S 3.95%
HQL Tekla Life Sciences Investors 2.75%
WSMRX William Blair Small-Mid Cap Growth R6 2.25%
HQH Tekla Healthcare Investors 1.59%
DBMCX BNY Mellon Sm/Md Cp Gr C 1.55%
JFNSX Janus Henderson Global Life Sciences S 1.31%
VISGX Vanguard Small Cap Growth Index Inv 0.70%
VBK Vanguard Small-Cap Growth ETF 0.70%
BBMC JPMorgan BetaBuilders US Mid Cap Eq ETF 0.60%
VB Vanguard Small-Cap ETF 0.34%
NAESX Vanguard Small Cap Index Inv 0.33%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.